BBHC
VCYT icon

Brown Brothers Harriman & Co’s Veracyte VCYT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-281
Closed -$5K – 1508
2022
Q3 		$5K Hold
281
– – ﹤0.01% 1310
2022
Q2 		$6K Buy
+281
New +$5.68K ﹤0.01% 1127

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Brown Brothers Harriman & Co's VCYT Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 281 shares — an estimated $5K sold.

Brown Brothers Harriman & Co first reported a position in VCYT in Q2 2022 and held it in 2 quarters. The position peaked at $6K in Q2 2022. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 281 Veracyte shares in Q4 2022, an estimated $5K.
  • Brown Brothers Harriman & Co first reported a position in Veracyte in Q2 2022 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's Veracyte position peaked at $6K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.